April 16, 2025: Parties in Trulicity Lawsuit to Hold Hearing on Gastroparesis On May 14, 2025, the parties involved in the Trulicity multidistrict litigation will hold a hearing about the reliable diagnostic process for gastroparesis
GLP-1 functions as an immune modulator because it controls macrophage polarization and T-cell functions [12,13]
Ongoing nutrition counseling when dose escalation produces nausea, early satiety, or marked reduction in food intake
No, there are currently no FDA-approved GLP-1 patches available for clinical use in the United States
A cooler bedroom and a warm shower 6090 minutes before bed
The skin settles into its new, improved rhythm